BIOSYNEX (EPA:ALBIO)

BRIEF

published on 12/19/2024 at 18:05, 1 day 19 hours ago

BIOSYNEX SA unveils its financial calendar for 2025

Financial Calendar Annual Results Turnover 2025 BIOSYNEX
BRIEF

published on 12/02/2024 at 08:05, 19 days 5 hours ago

BIOSYNEX: Agreement in Principle for Financial Reorganization and Capital Increase

Strategic Development Capital Increase Debt Restructuring BIOSYNEX Agreement In Principle
BRIEF

published on 11/04/2024 at 18:05, 1 month 16 days ago

BIOSYNEX SA: Declaration of Shares and Voting Rights

Voting Rights Actions Transparency Financial Markets BIOSYNEX
BRIEF

published on 10/23/2024 at 18:05, 1 month 28 days ago

Chembio Diagnostics wins grant for new syphilis test

BIOSYNEX Chembio Diagnostics Congenital Syphilis Rapid Diagnosis Gates Foundation Grant
PRESS RELEASE

published on 10/23/2024 at 18:00, 1 month 28 days ago

BIOSYNEX SA: CHEMBIO DIAGNOSTICS INC., A SUBSIDIARY OF BIOSYNEX, RECEIVES A GRANT FOR DEVELOPMENT OF A DPP CONGENITAL SYPHILIS ASSAY
Chembio Diagnostics Inc., a subsidiary of BIOSYNEX, receives a grant to develop a rapid point-of-care diagnostic test for congenital syphilis supported by the Bill & Melinda Gates Foundation

Grant BIOSYNEX Congenital Syphilis Chembio Diagnostics Inc. Bill & Melinda Gates Foundation
BRIEF

published on 10/17/2024 at 18:05, 2 months 3 days ago

BIOSYNEX SA: 2024 Half-Year Results and Debt Restructuring

Revenue Growth Half-year Results Debt Restructuring Cost Rationalization American Expansions
BRIEF

published on 07/18/2024 at 18:05, 5 months 2 days ago

BIOSYNEX: Revenue for the first half of 2024 up 26%

Acquisitions Growth Turnover Export American Subsidiaries
BRIEF

published on 05/28/2024 at 17:50, 6 months 23 days ago

BIOSYNEX obtains its first CE markings according to the new IVDR regulations

In Vitro Diagnostics BIOSYNEX IVDR CE Marking Rapid Tests
BRIEF

published on 05/28/2024 at 17:50, 6 months 23 days ago

BIOSYNEX Obtains Its First CE Markings According to IVDR Regulations

BIOSYNEX IVDR CE Marking Rapid Tests Molecular Biology
BRIEF

published on 05/13/2024 at 20:22, 7 months 7 days ago

BIOSYNEX strengthens its governance and promotes new talents

Governance Chief Operating Officer ESG BIOSYNEX Health Diagnosis

Published on 12/21/2024 at 01:30, 12 hours 20 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 12 hours 20 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 13 hours 45 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 13 hours 50 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 14 hours 20 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 12 hours 59 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 13 hours 5 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 18 hours 39 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 18 hours 54 minutes ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 19 hours 50 minutes ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 1 hour 32 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 19 hours 50 minutes ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 19 hours 55 minutes ago

Disclosure of trading in own shares from 16/12/2024 to 20/12/2024
Published on 12/20/2024 at 14:00, 23 hours 50 minutes ago

Safran: Woodward Signs Agreement to Acquire Safran’ s Electromechanical Actuation Business based in North America
Published on 12/19/2024 at 18:30, 1 day 19 hours ago

Share capital decrease by way of treasury shares cancellation

View all LES ECHOS COMFI WIRE

News